A Biphasic Osteovascular Biomimetic Scaffold for Rapid and Self-Sustained Endochondral Ossification
Overview
Biotechnology
Authors
Affiliations
Regeneration of large bones remains a challenge in surgery. Recent developmental engineering efforts aim to recapitulate endochondral ossification (EO), a critical step in bone formation. However, this process entails the condensation of mesenchymal stem cells (MSCs) into cartilaginous templates, which requires long-term cultures and is challenging to scale up. Here, a biomimetic scaffold is developed that allows rapid and self-sustained EO without initial hypertrophic chondrogenesis. The design comprises a porous chondroitin sulfate cryogel decorated with whitlockite calcium phosphate nanoparticles, and a soft hydrogel occupying the porous space. This composite scaffold enables human endothelial colony-forming cells (ECFCs) and MSCs to rapidly assemble into osteovascular niches in immunodeficient mice. These niches contain ECFC-lined blood vessels and perivascular MSCs that differentiate into RUNX2 OSX pre-osteoblasts after one week in vivo. Subsequently, multiple ossification centers are formed, leading to de novo bone tissue formation by eight weeks, including mature human OCN OPN osteoblasts, collagen-rich mineralized extracellular matrix, hydroxyapatite, osteoclast activity, and gradual mechanical competence. The early establishment of blood vessels is essential, and grafts that do not contain ECFCs fail to produce osteovascular niches and ossification centers. The findings suggest a novel bioengineering approach to recapitulate EO in the context of human bone regeneration.
Carriero V, Di Muzio L, Petralito S, Casadei M, Paolicelli P Gels. 2023; 9(12).
PMID: 38131965 PMC: 10742915. DOI: 10.3390/gels9120979.
Bone-Targeted Delivery of Cell-Penetrating-RUNX2 Fusion Protein in Osteoporosis Model.
Kim S, Lee H, Hong J, Kim S, Kwon E, Park T Adv Sci (Weinh). 2023; 10(28):e2301570.
PMID: 37574255 PMC: 10558633. DOI: 10.1002/advs.202301570.
El-Husseiny H, Mady E, Kaneda M, Shimada K, Nakazawa Y, Usui T Pharmaceutics. 2023; 15(7).
PMID: 37514092 PMC: 10384422. DOI: 10.3390/pharmaceutics15071906.
Jeyachandran D, Murshed M, Haglund L, Cerruti M Adv Healthc Mater. 2023; 12(25):e2300211.
PMID: 37462089 PMC: 11468889. DOI: 10.1002/adhm.202300211.
Pu Y, Lin X, Zhi Q, Qiao S, Yu C J Funct Biomater. 2023; 14(4).
PMID: 37103316 PMC: 10143991. DOI: 10.3390/jfb14040226.